As­traZeneca teams with Chi­na-owned fund to launch a new bio­phar­ma drug de­vel­op­ment com­pa­ny

As­traZeneca is part­ner­ing up with a gov­ern­ment-owned pri­vate eq­ui­ty group in Chi­na to cre­ate a new joint ven­ture bio­phar­ma that will be charged with de­vel­op­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER